Medicine and Dentistry
Patient
100%
Breast Cancer
88%
Neoplasm
48%
Lesion
39%
Neoadjuvant Chemotherapy
38%
Breast
34%
Magnetic Resonance Imaging
30%
Inpatient
29%
Triple Negative Breast Cancer
26%
Needle Biopsy
22%
Malignant Neoplasm
21%
Intraductal Carcinoma
19%
Prognostic Factor
19%
Diagnosis
19%
Age
18%
Fine-Needle Aspiration
16%
Protein P53
16%
Association
15%
Gamma Urogastrone
14%
Epidermal Growth Factor Receptor 2
14%
Woman
14%
Surgery
14%
Recurrent Disease
13%
Estrogen Receptor
13%
Lymph Node Metastasis
13%
Cyclooxygenase 2
12%
Evaluation Study
12%
Recurrence Free Survival
12%
Excision
12%
Breast Carcinoma
12%
Specimen
12%
Cells
12%
Chemotherapy
11%
Biopsy
11%
Prognosis
10%
Survival
9%
Overall Survival
9%
Combination Therapy
9%
Accuracy
9%
Case Report
9%
Analysis
8%
Lymph Node
8%
Disease Free Survival
8%
Hormone Receptor
8%
Metastatic Carcinoma
8%
Follow up
8%
Multivariate Analysis
8%
Phenotype
8%
Axillary Lymph Node
8%
Tumor Invasion
8%
Pharmacology, Toxicology and Pharmaceutical Science
Breast Cancer
33%
Chemotherapy
22%
Neoplasm
13%
Trastuzumab
13%
Prognosis
11%
Gamma Urogastrone
11%
Epidermal Growth Factor Receptor 2
11%
Metastatic Breast Cancer
9%
Overall Survival
9%
Survival
6%
Malignant Neoplasm
6%
Hormone Receptor
6%
Taxane
6%
Estrogen Receptor
5%
Disease Free Survival
5%
Protein P53
5%
Uterine Cervix Cancer
5%
Triple Negative Breast Cancer
5%
Progesterone Receptor
5%
Progression Free Survival
5%
Paclitaxel
5%
Recurrence Free Survival
5%
Lymph Node Metastasis
5%
Biochemistry, Genetics and Molecular Biology
Magnetic Resonance Imaging
23%
Epidermal Growth Factor Receptor
11%
Tumor Volume
8%
Age
7%
Survival
7%
Estrogen Receptor
7%
Disease Free Survival
7%
Phenotype
7%
Overall Survival
6%
Cancer Cell
6%
P53
6%
Association
5%
Magnetic Resonance Imaging of Breast
5%
Trastuzumab
5%
Doxorubicin
5%
Sirtuin1
5%
Protein Expression
5%